MYOCARDIAL INFARCTION
Preinfarction angina protects against out-of-hospital ventricular fibrillation in patients with acute occlusion of the left coronary artery
Peter J. Gheeraert, MD*,*,
José P. S. Henriques, MD ,
Marc L. De Buyzere, MSc*,
Michel De Pauw, MD*,
Yves Taeymans, MD, PhD* and
Felix Zijlstra, MD, PhD
* Department of Cardiology, University Hospital, Gent, Belgium
Department of Cardiology, De Weezenlanden Hospital, Zwolle, The Netherlands
Manuscript received February 16, 2001;
revised manuscript received June 14, 2001,
accepted July 19, 2001.
* Reprint requests and correspondence: Dr. Peter Gheeraert, Department of Cardiology, University Hospital, De Pintelaan 185, B-9000 Gent, Belgium peter.gheeraert{at}rug.ac.be
OBJECTIVES
The goal of this study was to evaluate the effect of preconditioning on out-of-hospital ventricular fibrillation (VF) in patients with acute myocardial infarction (AMI).
BACKGROUND
More than half of the deaths associated with AMI occur out of the hospital and within 1 h of symptom onset. In humans, preinfarction angina (PA), which can serve as a surrogate marker for preconditioning, reduces infarct size, but the protective effect against out-of-hospital VF has not been investigated.
METHODS
Preinfarction angina status and acute coronary angiographic findings of 72 consecutive patients with AMI complicated by out-of-hospital VF were compared with 144 matched controls without this complication.
RESULTS
Preinfarction angina is associated with a lower risk for VF (odds ratio [OR]: 0.40, 95% confidence interval [CI]: 0.18 to 0.88). In patients with acute occlusion of the left coronary artery (LCA) (n = 136), the risk reduction is pronounced (OR: 0.25, 95% CI: 0.10 to 0.66), whereas, in patients with acute occlusion of the right coronary artery (RCA) (n = 67), the protective effect of PA on VF was not observed (OR: 2.25, 95% CI: 0.45 to 11.22). Subgroup and multivariate analyses show that the protective effect is independent of cardiovascular risk factors, preinfarction treatment with beta-adrenergic blocking agents or aspirin, the presence of collaterals or residual antegrade flow or the extent of coronary artery disease.
CONCLUSIONS
Preinfarction angina protects against out-of-hospital VF in patients with acute occlusion of the LCA. This protection is independent of risk factors or coronary anatomy. A larger study is needed to examine the apparently different effect in patients with acute occlusion of the RCA.
|
Abbreviations and Acronyms
| | AMI | = acute myocardial infarction | | CAD | = coronary artery disease | | CI | = confidence interval | | IRA | = infarct-related coronary artery | | LCA | = left coronary artery | | MI | = myocardial infarction | | OR | = odds ratio | | PA | = preinfarction angina | | RCA | = right coronary artery | | VF | = ventricular fibrillation |
|
This article has been cited by other articles:

|
 |

|
 |
 
K. Iwakura, H. Ito, S. Kawano, A. Okamura, T. Kurotobi, M. Date, K. Inoue, and K. Fujii
Chronic pre-treatment of statins is associated with the reduction of the no-reflow phenomenon in the patients with reperfused acute myocardial infarction
Eur. Heart J.,
March 1, 2006;
27(5):
534 - 539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R J Edwards, S R Redwood, P D Lambiase, E Tomset, R D Rakhit, and M S Marber
Antiarrhythmic and anti-ischaemic effects of angina in patients with and without coronary collaterals
Heart,
December 1, 2002;
88(6):
604 - 610.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|